{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T13:12:46Z","timestamp":1776172366422,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca PLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hellenic Journal of Cardiology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.hjc.2024.06.009","type":"journal-article","created":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T02:51:51Z","timestamp":1719629511000},"page":"52-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Ticagrelor potentiates cardioprotection by remote ischemic preconditioning: the ticagrelor in remote ischemic preconditioning (TRIP) randomized clinical trial"],"prefix":"10.1016","volume":"87","author":[{"given":"Ioannis","family":"Tsiafoutis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodoros","family":"Zografos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2924-8793","authenticated-orcid":false,"given":"Dimitrios","family":"Karelas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3578-1228","authenticated-orcid":false,"given":"Panagiotis","family":"Varelas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Manousopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Nenekidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Koutouzis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8067-677X","authenticated-orcid":false,"given":"Panagiotis","family":"Lagadinos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Koudounis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Agelaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantina","family":"Katsanou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8079-0599","authenticated-orcid":false,"given":"Evangelos","family":"Oikonomou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerasimos","family":"Siasos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apostolos","family":"Katsivas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hjc.2024.06.009_bib1","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1161\/CIRCINTERVENTIONS.110.959080","article-title":"Periprocedural myocardial infarction: prevalence, prognosis, and prevention","volume":"3","author":"Lansky","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.hjc.2024.06.009_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/eurheartj\/ehq393","article-title":"Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotection","volume":"32","author":"Babu","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hjc.2024.06.009_bib3","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1161\/01.CIR.0000156328.28485.AD","article-title":"Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging","volume":"111","author":"Selvanayagam","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.hjc.2024.06.009_bib4","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.jacc.2016.08.059","article-title":"High-sensitivity troponin T and mortality after elective percutaneous coronary intervention","volume":"68","author":"Ndrepepa","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hjc.2024.06.009_bib5","first-page":"318","article-title":"Prognostic value of troponin after elective percutaneous coronary intervention: a meta-analysis","volume":"71","author":"Nienhuis","year":"2008","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.hjc.2024.06.009_bib6","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/eurheartj\/ehx799","article-title":"Periprocedural myocardial infarction and injury in elective coronary stenting","volume":"39","author":"Zeitouni","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hjc.2024.06.009_bib7","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nrcardio.2011.85","article-title":"The therapeutic potential of ischemic conditioning: an update","volume":"8","author":"Hausenloy","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.hjc.2024.06.009_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/6907167","article-title":"Effect of remote ischemic preconditioning on perioperative cardiac events in patients undergoing elective percutaneous coronary intervention: a meta-analysis of 16 randomized trials","volume":"2017","author":"Wang","year":"2017","journal-title":"Cardiol Res Pract"},{"key":"10.1016\/j.hjc.2024.06.009_bib9","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005522","article-title":"Remote ischemic perconditioning to reduce reperfusion injury during acute ST-segment-elevation myocardial infarction: a systematic review and meta-analysis","volume":"6","author":"McLeod","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hjc.2024.06.009_bib10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ijcard.2017.02.028","article-title":"Effect of remote ischemia or nicorandil on myocardial injury following percutaneous coronary intervention in patients with stable coronary artery disease: a randomized controlled trial","volume":"236","author":"Miyoshi","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hjc.2024.06.009_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2017.12.033","article-title":"The EUROpean and Chinese cardiac and renal Remote Ischemic Preconditioning Study (EURO-CRIPS CardioGroup I): a randomized controlled trial","volume":"257","author":"Moretti","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hjc.2024.06.009_bib12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/cvr\/cvn114","article-title":"Remote ischaemic preconditioning: underlying mechanisms and clinical application","volume":"79","author":"Hausenloy","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hjc.2024.06.009_bib13","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1152\/physrev.00009.2003","article-title":"Preconditioning the myocardium: from cellular physiology to clinical cardiology","volume":"83","author":"Yellon","year":"2003","journal-title":"Physiol Rev"},{"key":"10.1016\/j.hjc.2024.06.009_bib14","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1161\/01.CIR.84.1.350","article-title":"Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart","volume":"84","author":"Liu","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.hjc.2024.06.009_bib15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/1074248413511693","article-title":"Characterization of the adenosine pharmacology of ticagrelor reveals therapeutically relevant inhibition of equilibrative nucleoside transporter 1","volume":"19","author":"Armstrong","year":"2014","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.hjc.2024.06.009_bib16","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/1074248411410883","article-title":"Ticagrelor inhibits adenosine uptake in vitro and enhances adenosine-mediated hyperemia responses in a canine model","volume":"17","author":"van Giezen","year":"2012","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.hjc.2024.06.009_bib17","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1111\/jth.12360","article-title":"Ticagrelor inhibits human platelet aggregation via adenosine in addition to P2Y12 antagonism","volume":"11","author":"Nylander","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.hjc.2024.06.009_bib18","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/bph.13429","article-title":"Effects of P2Y12 receptor antagonists beyond platelet inhibition--comparison of ticagrelor with thienopyridines","volume":"173","author":"Nylander","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.hjc.2024.06.009_bib19","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jacc.2013.09.067","article-title":"Ticagrelor increases adenosine plasma concentration in patients with an acute coronary syndrome","volume":"63","author":"Bonello","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hjc.2024.06.009_bib20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1161\/CIRCINTERVENTIONS.113.000293","article-title":"Differential effect of ticagrelor versus prasugrel on coronary blood flow velocity in patients with non-ST-elevation acute coronary syndrome undergoing percutaneous coronary intervention: an exploratory study","volume":"6","author":"Alexopoulos","year":"2013","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.hjc.2024.06.009_bib21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hjc.2024.06.009_bib22","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.hjc.2024.06.009_bib23","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/j.amjcard.2014.03.043","article-title":"Effect of one-cycle remote ischemic preconditioning to reduce myocardial injury during percutaneous coronary intervention","volume":"113","author":"Zografos","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hjc.2024.06.009_bib24","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1161\/CIRCULATIONAHA.108.809723","article-title":"Cardiac remote ischemic preconditioning in coronary stenting (CRISP stent) study: a prospective, randomized control trial","volume":"119","author":"Hoole","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.hjc.2024.06.009_bib25","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.jclinepi.2007.02.006","article-title":"A simple sample size formula for analysis of covariance in randomized clinical trials","volume":"60","author":"Borm","year":"2007","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.hjc.2024.06.009_bib26","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3758\/BF03195405","article-title":"Power analysis for multivariate and repeated measures designs: a flexible approach using the SPSS MANOVA procedure","volume":"33","author":"D'Amico","year":"2001","journal-title":"Behav Res Methods Instrum Comput"},{"key":"10.1016\/j.hjc.2024.06.009_bib27","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.hjc.2024.06.009_bib28","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1253\/circj.CJ-15-0112","article-title":"Ticagrelor vs. clopidogrel in Japanese, Korean and Taiwanese patients with acute coronary syndrome -- randomized, double-blind, phase III PHILO study","volume":"79","author":"Goto","year":"2015","journal-title":"Circ J"},{"issue":"10207","key":"10.1016\/j.hjc.2024.06.009_bib29","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(19)32039-2","article-title":"Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2\/ERIC-PPCI): a single-blind randomised controlled trial","volume":"394","author":"Hausenloy","year":"2019","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.hjc.2024.06.009_bib30","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s10557-022-07345-9","article-title":"Platelet-mediated transfer of cardioprotection by remote ischemic conditioning and its abrogation by aspirin but not by ticagrelor","volume":"37","author":"Lieder","year":"2023","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.hjc.2024.06.009_bib31","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.acvd.2016.04.001","article-title":"Pleiotropic effects of ticagrelor: myth or reality?","volume":"109","author":"Ait Mokhtar","year":"2016","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.hjc.2024.06.009_bib32","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1161\/CIRCULATIONAHA.116.024710","article-title":"The dogged search for cryptic effects of ticagrelor: wishful thinking or real benefits beyond P2Y12 inhibition?","volume":"134","author":"Gurbel","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.hjc.2024.06.009_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137560","article-title":"Ticagrelor does not inhibit adenosine transport at relevant concentrations: a randomized cross-over study in healthy subjects in vivo","volume":"10","author":"van den Berg","year":"2015","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.hjc.2024.06.009_bib34","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.jcin.2018.04.022","article-title":"Effects of ticagrelor, prasugrel, or clopidogrel on endothelial function and other vascular biomarkers: a randomized crossover study","volume":"11","author":"Ariotti","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.hjc.2024.06.009_bib35","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1164\/ajrccm.159.3.9803100","article-title":"Plasma concentration of adenosine during normoxia and moderate hypoxia in humans","volume":"159","author":"Saito","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hjc.2024.06.009_bib36","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1182\/blood-2016-03-707844","article-title":"Inverse agonism at the P2Y12 receptor and ENT1 transporter blockade contribute to platelet inhibition by ticagrelor","volume":"128","author":"Aungraheeta","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hjc.2024.06.009_bib37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00395-021-00851-1","article-title":"Vascular conditioning prevents adverse left ventricular remodelling after acute myocardial infarction: a randomised remote conditioning study","volume":"116","author":"Ikonomidis","year":"2021","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.hjc.2024.06.009_bib38","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1161\/CIRCINTERVENTIONS.112.000184","article-title":"Remote ischemic preconditioning improves outcome at 6 years after elective percutaneous coronary intervention: the CRISP stent trial long-term follow-up","volume":"6","author":"Davies","year":"2013","journal-title":"Circ Cardiovasc Interv"}],"container-title":["Hellenic Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1109966624001337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1109966624001337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T12:38:45Z","timestamp":1776170325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1109966624001337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":38,"alternative-id":["S1109966624001337"],"URL":"https:\/\/doi.org\/10.1016\/j.hjc.2024.06.009","relation":{},"ISSN":["1109-9666"],"issn-type":[{"value":"1109-9666","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ticagrelor potentiates cardioprotection by remote ischemic preconditioning: the ticagrelor in remote ischemic preconditioning (TRIP) randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"Hellenic Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hjc.2024.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Hellenic Society of Cardiology. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}